Screening for Exercise-Induced Laryngeal Dysfunction: Evidence, Mechanisms, and Clinical Approaches

Abstract

Exercise-induced laryngeal dysfunction (EILD) is an increasingly recognized condition characterized by transient, inappropriate laryngeal closure during physical exertion, leading to exertional dyspnea and upper airway obstruction symptoms that can mimic or coexist with asthma. Despite its clinical significance, EILD remains underdiagnosed, often resulting in inappropriate treatment and persistent symptoms. This review synthesizes the epidemiology, pathophysiology, risk factors, clinical features, and diagnostic strategies for EILD, with a focus on evidence-based screening, recent advances, and guideline recommendations. Emphasis is placed on the importance of early recognition and multidisciplinary management to optimize outcomes in affected individuals.

Introduction

Exercise-induced laryngeal dysfunction represents a spectrum of transient abnormalities in laryngeal function that occur during exercise, most commonly manifesting as exercise-induced laryngeal obstruction (EILO). This condition poses diagnostic challenges due to symptom overlap with exercise-induced bronchoconstriction and asthma, leading to frequent misdiagnosis. Timely and accurate screening is essential for targeted interventions, improved patient outcomes, and avoidance of unnecessary pharmacologic therapies. This article provides a comprehensive, evidence-based overview of EILD, tailored for clinicians and healthcare professionals involved in respiratory, sports, and otolaryngologic medicine.

Epidemiology / Disease Burden

The true prevalence of EILD is difficult to ascertain due to underrecognition and varying diagnostic criteria. Recent studies suggest that EILO may affect up to 5-7% of adolescents and young adults, with a higher predilection in females and athletes engaged in high-intensity sports. EILD is a significant contributor to exercise-induced respiratory symptoms in non-asthmatic populations and is reported to coexist with asthma in up to 30% of cases. The disease burden is compounded by misdiagnosis, leading to unnecessary inhaled corticosteroids, beta-agonists, and activity limitations, with potential psychological impacts in athletic and non-athletic populations alike.

Pathophysiology

The pathophysiology of EILD centers on paradoxical adduction of the vocal folds and/or supraglottic structures during inspiration under exertion, resulting in variable upper airway obstruction. Mechanistically, it is hypothesized that heightened laryngeal sensitivity, altered neuromuscular control, or maladaptive laryngeal reflexes contribute to inappropriate closure. Psychological stress, heightened sympathetic tone, and increased airway turbulence during high ventilatory demand may further exacerbate these phenomena. Recent imaging and laryngoscopic studies have elucidated the dynamic nature of EILD, differentiating glottic from supraglottic phenotypes, which may have distinct clinical implications.

Risk Factors

Risk factors for EILD include female gender, adolescent age, high levels of athletic engagement, underlying atopy, and a personal or family history of anxiety or psychological stress. Certain sports, such as swimming, track and field, and cycling, have higher reported incidences, possibly due to increased ventilatory demand and environmental exposures. Pre-existing laryngeal hypersensitivity or history of upper respiratory infection may predispose individuals to laryngeal dysfunction during exertion.

Clinical Features

EILD typically presents as inspiratory stridor, throat tightness, dyspnea, or choking sensations during high-intensity exercise, with rapid resolution upon cessation of activity. Unlike bronchoconstriction, symptoms are predominantly inspiratory, and patients may demonstrate minimal response to bronchodilators. Associated features may include dysphonia and cough, with symptom provocation reproducible during exercise testing. The temporal relationship between onset and exertion, coupled with lack of improvement with asthma medications, should prompt consideration of EILD.

Diagnosis

Accurate diagnosis relies on a high index of suspicion and systematic screening of individuals with exertional respiratory symptoms unresponsive to standard asthma therapy. The gold standard diagnostic modality is continuous laryngoscopy during exercise (CLE), which allows real-time visualization of laryngeal dynamics. Ancillary tests may include spirometry, exercise challenge testing, and exclusion of alternative causes such as asthma, vocal cord dysfunction, or structural airway lesions. Screening questionnaires and symptom checklists can aid in identifying patients who warrant further evaluation.

Treatment & Management

Management is multidisciplinary, focusing on patient education, behavioral therapy, and targeted laryngeal control exercises. Speech and language therapy, incorporating biofeedback and breathing retraining, has demonstrated efficacy in reducing symptom burden and improving exercise tolerance. Psychological support may be warranted, particularly in individuals with significant anxiety or stress-related triggers. Pharmacologic interventions are limited, with little evidence supporting routine use of inhaled corticosteroids or beta-agonists in isolated EILD. In rare, refractory cases, surgical interventions such as supraglottoplasty may be considered, particularly for severe supraglottic collapse.

Recent Advances / Emerging Therapies

Emerging evidence supports the role of real-time CLE as both a diagnostic and therapeutic tool, allowing biofeedback-guided therapy and individualized management. Novel interventions, including portable laryngoscopy devices and telemedicine-based therapy platforms, are expanding access to specialized care. Ongoing research into neuromodulation and the role of laryngeal desensitization techniques holds promise for future non-invasive treatments. Additionally, advances in machine learning are being explored to automate and enhance screening accuracy using symptom profiles and laryngoscopic images.

Guideline Recommendations

Recent consensus guidelines advocate for routine consideration of EILD in all patients, particularly athletes, presenting with exertional dyspnea unresponsive to asthma therapies. Early referral for CLE is recommended when initial screening suggests laryngeal dysfunction. Multidisciplinary management, incorporating otolaryngologists, pulmonologists, speech-language pathologists, and sports medicine specialists, is advised to optimize outcomes. Guidelines emphasize the importance of avoiding unnecessary pharmacologic interventions and the need for ongoing research to refine diagnostic and therapeutic algorithms.

Conclusion

Exercise-induced laryngeal dysfunction is a clinically significant but underdiagnosed condition that requires heightened awareness and systematic screening in individuals with exertional respiratory symptoms. Advances in diagnostic modalities and multidisciplinary treatment approaches have improved recognition and management, but continued research is needed to optimize screening strategies and therapeutic interventions. Early identification, precise diagnosis, and individualized care remain the cornerstones of improving patient quality of life and functional outcomes in EILD.